Pharming Group Correlations
| PHAR Stock | USD 10.23 0.02 0.20% |
The current 90-days correlation between Pharming Group NV and Pharming Group NV is 0.09 (i.e., Significant diversification). The correlation of Pharming Group is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Pharming Group Correlation With Market
Modest diversification
The correlation between Pharming Group NV and DJI is 0.22 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Pharming Group NV and DJI in the same portfolio, assuming nothing else is changed.
Moving together with Pharming Stock
| 0.69 | RCUS | Arcus Biosciences | PairCorr |
| 0.65 | CGEN | Compugen | PairCorr |
| 0.79 | KB | KB Financial Group | PairCorr |
| 0.66 | SHG | Shinhan Financial Earnings Call This Week | PairCorr |
| 0.73 | CSCO | Cisco Systems | PairCorr |
| 0.71 | IBM | International Business Earnings Call Tomorrow | PairCorr |
| 0.61 | AA | Alcoa Corp | PairCorr |
| 0.75 | MSFT | Microsoft Aggressive Push | PairCorr |
| 0.8 | DIS | Walt Disney | PairCorr |
| 0.67 | AXP | American Express | PairCorr |
Moving against Pharming Stock
| 0.34 | KO | Coca Cola Earnings Call Today | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Pharming Stock performing well and Pharming Group Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Pharming Group's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| PHGUF | 0.98 | 0.42 | 0.00 | (2.49) | 0.00 | 3.60 | 25.72 | |||
| PRTC | 1.96 | 0.35 | 0.05 | (0.53) | 2.47 | 5.53 | 13.98 | |||
| ETON | 2.43 | (0.03) | (0.02) | 0.10 | 3.07 | 5.47 | 23.35 | |||
| GNTA | 2.65 | 0.07 | (0.02) | (0.33) | 3.37 | 4.74 | 29.79 | |||
| PHVS | 3.38 | 0.82 | 0.23 | 1.28 | 2.97 | 7.45 | 31.93 | |||
| NBTX | 3.42 | 0.65 | 0.15 | 1.84 | 3.23 | 10.98 | 21.20 | |||
| PHAT | 6.43 | 1.36 | 0.20 | 1.72 | 6.03 | 10.95 | 99.31 | |||
| SLN | 4.03 | 1.36 | 0.35 | (3.46) | 2.85 | 8.98 | 20.04 |
Pharming Group Corporate Management
| Michael Levitan | VP Communications | Profile | |
| Bruno Giannetti | Consultant | Profile | |
| Susanne Embleton | Investor Manager | Profile | |
| Jeroen Wakkerman | Chief Officer | Profile | |
| Stephen Toor | Chief Americas | Profile | |
| MBA MD | CEO Pres | Profile |